ETF Exchange > FTXH ETF
FTXH - ETF Fact Sheet
First Trust Nasdaq Pharmaceuticals ETF - USD
Fund Identification
Ticker
FTXH
ISIN
US33738R8372
Main Metrics
Price
$38.49Expense Ratio
0.6%AuM
$55.82MTracking Difference
-1.05%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
FTXH's historical prices, performance, and flows
1m returns
7.68%
1m flows
$19M
* Net total returns
All data as of 16 July 2026
The ETF Exchange is brought to you by
With data and analysis by
See all FTXH data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
FTXH's characteristics
Manager
Manager statistics
415 funds, $288.88Bn in AUM
Benchmark
NASDAQ US Smart Pharmaceuticals Total Return Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
FTXH's exposure
Countries
USA
95.60%
Sectors
Healthcare
100.00%
Top 5 holdings
Eli Lilly & Co.
7.78%
Merck & Co., Inc.
7.03%
AbbVie, Inc.
6.94%
Johnson & Johnson
6.80%
Bristol Myers Squibb Co.
6.66%
Total holdings
50
Total weight of top 5
35.21%
